Skip to main content
Caplight Logo









KiraGen Bio

KiraGen Bio

Private
MassachusettsHealthcare & Life Scienceshttps://www.kiragenbio.com/

Last Round

Grant

Dec 31, 2025

Total Funding Raised

$1.45M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

KiraGen Bio is a biotechnology company that develops multiplex gene-edited CAR-T cell therapies designed to overcome the immunosuppressive tumor microenvironment in solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

CAR-T cell therapymultiplex gene editingAI drug discoverysolid tumor therapycell therapyglioblastoma treatmenttumor microenvironmentTMEoff-the-shelf cell therapyallogeneic cell therapyAI bioprecision medicinebiotech startupgene editing platformsynthetic biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KiraGen Bio Comparables

Compare KiraGen Bio with similar companies based on industry and business-model similarity.

KiraGen Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Outpace Bio
78%
ArsenalBio
77%
T-MAXIMUM Pharmaceutical
76%

KiraGen Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 31, 2025
AcceleratorApr 23, 2025
Pre SeedApr 1, 2025

Key People

Founding team and executive leadership

Ryan Murray

Co-Founder Chief Scientific Officer

Founding Team

Aaron Edwards

Co-Founder CEO

Founding Team

KiraGen Bio Investors

Notable investors and investment history

KiraGen Bio investors
InvestorRounds
Lexi VenturesPre Seed
Harvard Innovation LabsPre Seed
GaingelsPre Seed
Yuvaan Tiwari FoundationPre Seed
ZAKA VCPre Seed
Conscience VCPre Seed
2048 VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 31, 2025

    Secured $50K in grant funding.

  • Jul 12, 2025

    Featured on The Sheekey Science Show.

KiraGen Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

KiraGen Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about KiraGen Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersMassachusetts
Employee Range6
Year Founded2023
Last FundingDec 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?